237 related articles for article (PubMed ID: 31398858)
1. Brain White Matter: A Substrate for Resilience and a Substance for Subcortical Small Vessel Disease.
Sorond FA; Gorelick PB
Brain Sci; 2019 Aug; 9(8):. PubMed ID: 31398858
[TBL] [Abstract][Full Text] [Related]
2. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
[TBL] [Abstract][Full Text] [Related]
3. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
[TBL] [Abstract][Full Text] [Related]
4. Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.
Ding J; Sigurðsson S; Jónsson PV; Eiriksdottir G; Charidimou A; Lopez OL; van Buchem MA; Guðnason V; Launer LJ
JAMA Neurol; 2017 Sep; 74(9):1105-1112. PubMed ID: 28715552
[TBL] [Abstract][Full Text] [Related]
5. Dilated perivascular spaces in small-vessel disease: a study in CADASIL.
Yao M; Hervé D; Jouvent E; Duering M; Reyes S; Godin O; Guichard JP; Dichgans M; Chabriat H
Cerebrovasc Dis; 2014; 37(3):155-63. PubMed ID: 24503815
[TBL] [Abstract][Full Text] [Related]
6. Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients.
Loos CM; Klarenbeek P; van Oostenbrugge RJ; Staals J
PLoS One; 2015; 10(9):e0137323. PubMed ID: 26352265
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
[TBL] [Abstract][Full Text] [Related]
9. Total cerebral small vessel disease score and cognitive performance in community-dwelling older adults. Results from the Atahualpa Project.
Del Brutto VJ; Ortiz JG; Del Brutto OH; Mera RM; Zambrano M; Biller J
Int J Geriatr Psychiatry; 2018 Feb; 33(2):325-331. PubMed ID: 28548298
[TBL] [Abstract][Full Text] [Related]
10. Cerebral small vessel disease and renal function: systematic review and meta-analysis.
Makin SD; Cook FA; Dennis MS; Wardlaw JM
Cerebrovasc Dis; 2015; 39(1):39-52. PubMed ID: 25547195
[TBL] [Abstract][Full Text] [Related]
11. Total Cerebral Small Vessel Disease MRI Score Is Associated with Cognitive Decline in Executive Function in Patients with Hypertension.
Uiterwijk R; van Oostenbrugge RJ; Huijts M; De Leeuw PW; Kroon AA; Staals J
Front Aging Neurosci; 2016; 8():301. PubMed ID: 28018214
[No Abstract] [Full Text] [Related]
12. Structural Covariance Networks and Their Association with Age, Features of Cerebral Small-Vessel Disease, and Cognitive Functioning in Older Persons.
Foster-Dingley JC; Hafkemeijer A; van den Berg-Huysmans AA; Moonen JE; de Ruijter W; de Craen AJ; van der Mast RC; Rombouts SA; van der Grond J
Brain Connect; 2016 Nov; 6(9):681-690. PubMed ID: 27506114
[TBL] [Abstract][Full Text] [Related]
13. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
14. Exploring causal pathways linking cerebral small vessel diseases burden to poststroke depressive symptoms with structural equation model analysis.
Liang Y; Chen YK; Liu YL; Mok VCT; Ungvari GS; Chu WCW; Tang WK; Kim JS; Kim JM
J Affect Disord; 2019 Jun; 253():218-223. PubMed ID: 31054447
[TBL] [Abstract][Full Text] [Related]
15. The relation between total cerebral small vessel disease burden and gait impairment in patients with minor stroke.
Loos CM; McHutchison C; Cvoro V; Makin SD; Staals J; Chappell F; Dennis MS; van Oostenbrugge RJ; Wardlaw JM
Int J Stroke; 2018 Jul; 13(5):518-524. PubMed ID: 28906203
[TBL] [Abstract][Full Text] [Related]
16. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.
Jokinen H; Koikkalainen J; Laakso HM; Melkas S; Nieminen T; Brander A; Korvenoja A; Rueckert D; Barkhof F; Scheltens P; Schmidt R; Fazekas F; Madureira S; Verdelho A; Wallin A; Wahlund LO; Waldemar G; Chabriat H; Hennerici M; O'Brien J; Inzitari D; Lötjönen J; Pantoni L; Erkinjuntti T
Stroke; 2020 Jan; 51(1):170-178. PubMed ID: 31699021
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension.
Jiménez-Balado J; Riba-Llena I; Abril O; Garde E; Penalba A; Ostos E; Maisterra O; Montaner J; Noviembre M; Mundet X; Ventura O; Pizarro J; Delgado P
Hypertension; 2019 Feb; 73(2):342-349. PubMed ID: 30606062
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness.
Gustavsson AM; Stomrud E; Abul-Kasim K; Minthon L; Nilsson PM; Hansson O; Nägga K
Cerebrovasc Dis Extra; 2015; 5(2):41-51. PubMed ID: 26120319
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study.
Wang N; Allali G; Kesavadas C; Noone ML; Pradeep VG; Blumen HM; Verghese J
J Alzheimers Dis; 2016; 50(3):699-707. PubMed ID: 26757037
[TBL] [Abstract][Full Text] [Related]
20. C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers.
Hilal S; Ikram MA; Verbeek MM; Franco OH; Stoops E; Vanderstichele H; Niessen WJ; Vernooij MW
Stroke; 2018 Nov; 49(11):2692-2698. PubMed ID: 30355213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
